- Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
-
Goh MJ, Sinn DH
- KMID: 2531366
- Clin Mol Hepatol.
- 2022 Jul;28(3):380-395.
- doi: 10.3350/cmh.2021.0366
Preclinical studies highlighted potential therapeutic applications of aspirin and statins as anticancer agents based on their pleiotropic effects. Epidemiologic studies suggested the role of aspirin and statins in the chemoprevention... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
-
Goh MJ, Sinn DH, Kim JM, Lee MW, Hyun DH, Yu JI, Hong JY, Choi MS
- KMID: 2541399
- Clin Mol Hepatol.
- 2023 Apr;29(2):197-205.
- doi: 10.3350/cmh.2022.0404
Hepatocellular carcinoma (HCC) is a major cause of death in many countries, including South Korea. To provide useful and sensible advice for clinical management of patients with HCC, the Korean... -
- CITED
-
- Close
- SHARE
-
- Close
- Advanced Stage Hepatocellular Carcinoma Successfully Treated with Transarterial Radioembolization and Multi-tyrosine Kinase Inhibitor Therapy
-
Goh MJ, Kang W, Sinn DH, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW
- KMID: 2508028
- J Liver Cancer.
- 2020 Sep;20(2):160-166.
- doi: 10.17998/jlc.20.2.160
Transarterial radioembolization (TARE) with yttrium-90 microspheres has become widely utilized in managing hepatocellular carcinoma (HCC). The utility of TARE is expanding with new insights through experiences from real-world practice and... -
- CITED
-
- Close
- SHARE
-
- Close
- Nomogram for predicting overall survival in patients with large (>5 cm) hepatocellular carcinoma based on real-world practice
-
Kim N, Yu JI, Park HC, Hong JY, Lim HY, Goh MJ, Paik YH
- KMID: 2546415
- J Liver Cancer.
- 2023 Sep;23(2):350-361.
- doi: 10.17998/jlc.2023.08.10
Background/Aim: Patients with large (>5 cm) hepatocellular carcinoma (HCC) have limited treatment options, thus necessitating the identification of prognostic factors and the development of predictive tools. This study aimed to... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence and predictors of multidrug-resistant bacteremia in liver cirrhosis
-
Kim A, Song BG, Kang W, Sinn DH, Gwak GY, Paik YH, Choi MS, Lee JH, Goh MJ
- KMID: 2554890
- Korean J Intern Med.
- 2024 May;39(3):448-457.
- doi: 10.3904/kjim.2023.354
Background/Aims: Improved knowledge of local epidemiology and predicting risk factors of multidrug-resistant (MDR) bacteria are required to optimize the management of infections. This study examined local epidemiology and antibiotic resistance... -
- CITED
-
- Close
- SHARE
-
- Close
- Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy
-
Song BG, Goh MJ, Kang W, Sinn DH, Gwak GY, Paik YH, Lee JH, Choi MS
- KMID: 2559471
- J Liver Cancer.
- 2024 Sep;24(2):243-252.
- doi: 10.17998/jlc.2024.05.26
Backgrounds/Aims: Systemic therapy is the current standard treatment for hepatocellular carcinoma (HCC) with extrahepatic metastasis (EHM). However, some patients with HCC and EHM undergo transarterial chemoembolization (TACE) to manage intrahepatic... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Three, Motion-Resistant MR Sequences on Hepatobiliary Phase for Gadoxetic Acid (Gd-EOB-DTPA)-Enhanced MR Imaging of the Liver
-
Kim DR, Kim BS, Lee JS, Choi GM, Kim SH, Goh MJ, Song BC, Lee MS, Lee KR, Ko SY
- KMID: 2385603
- Investig Magn Reson Imaging.
- 2017 Jun;21(2):71-81.
- doi: 10.13104/imri.2017.21.2.71
PURPOSE: To compare three, motion-resistant, T1-weighted MR sequences on the hepatobiliary phase for gadoxetic acid-enhanced MR imaging of the liver. MATERIALS AND METHODS: In this retrospective study, 79 patients underwent gadoxetic... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcomes and Validation of Ursodeoxycholic Acid Response Scores in Patients with Korean Primary Biliary Cholangitis: A Multicenter Cohort Study
-
Chang JI, Kim JH, Sinn DH, Cho JY, Kim KM, Oh JH, Park Y, Sohn W, Goh MJ, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW
- KMID: 2544904
- Gut Liver.
- 2023 Jul;17(4):620-628.
- doi: 10.5009/gnl220420
Background/Aims: The ursodeoxycholic acid (UDCA) response score (URS) was developed to identify poor responders to UDCA before treatment, in order to offer timely and proactive intervention. However, validation of the... -
- CITED
-
- Close
- SHARE
-
- Close
